Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha-globin locus is a critical genomic region located on chromosome 16 (16p13.3) that contains the HBA1 and HBA2 genes, which are responsible for encoding the alpha-globin subunits of human hemoglobin. In healthy hematopoietic stem and progenitor cells (HSPCs), the expression of this locus is tightly regulated to maintain a 1:1 stoichiometric ratio with beta-globin chains, ensuring the formation of stable hemoglobin tetramers. In the context of beta-thalassemia, a deficiency in beta-globin leads to a relative excess of alpha-globin chains, which precipitate and cause oxidative damage to erythroid precursors, resulting in ineffective erythropoiesis. Consequently, the alpha-globin locus has become a primary target for therapeutic gene editing; by downregulating alpha-globin production through the disruption of the genes or their distal enhancers (such as MCS-R2), researchers aim to restore the globin balance and alleviate disease symptoms. Current experimental approaches utilize advanced genetic tools like CRISPR-Cas9 and base editors to modify patient-derived HSPCs ex vivo before re-infusion. This strategy represents a promising curative pathway for patients with severe hemoglobinopathies by improving the survival and functionality of mature red blood cells.
Reduction of alpha-globin chain synthesis via gene disruption or enhancer deletion to mitigate alpha/beta-globin chain imbalance in beta-thalassemia, or restoration of alpha-globin expression via gene addition/correction in alpha-thalassemia.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-globin locus (HBA locus).